» Articles » PMID: 17584830

Soluble Erythropoietin Receptor is Present in the Mouse Brain and is Required for the Ventilatory Acclimatization to Hypoxia

Overview
Journal J Physiol
Specialty Physiology
Date 2007 Jun 23
PMID 17584830
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

While erythropoietin (Epo) and its receptor (EpoR) have been widely investigated in brain, the expression and function of the soluble Epo receptor (sEpoR) remain unknown. Here we demonstrate that sEpoR, a negative regulator of Epo's binding to the EpoR, is present in the mouse brain and is down-regulated by 62% after exposure to normobaric chronic hypoxia (10% O2 for 3 days). Furthermore, while normoxic minute ventilation increased by 58% in control mice following hypoxic acclimatization, sEpoR infusion in brain during the hypoxic challenge efficiently reduced brain Epo concentration and abolished the ventilatory acclimatization to hypoxia (VAH). These observations imply that hypoxic downregulation of sEpoR is required for adequate ventilatory acclimatization to hypoxia, thereby underlying the function of Epo as a key factor regulating oxygen delivery not only by its classical activity on red blood cell production, but also by regulating ventilation.

Citing Articles

High altitude polycythemia and its maladaptive mechanisms: an updated review.

Tang S, Zhou W, Chen L, Yan H, Chen L, Luo F Front Med (Lausanne). 2024; 11:1448654.

PMID: 39257892 PMC: 11383785. DOI: 10.3389/fmed.2024.1448654.


Electrical epidural stimulation of the cervical spinal cord: implications for spinal respiratory neuroplasticity after spinal cord injury.

Malone I, Nosacka R, Nash M, Otto K, Dale E J Neurophysiol. 2021; 126(2):607-626.

PMID: 34232771 PMC: 8409953. DOI: 10.1152/jn.00625.2020.


Mitochondrial Metabolism as Target of the Neuroprotective Role of Erythropoietin in Parkinson's Disease.

Rey F, Ottolenghi S, Giallongo T, Balsari A, Martinelli C, Rey R Antioxidants (Basel). 2021; 10(1).

PMID: 33467745 PMC: 7830512. DOI: 10.3390/antiox10010121.


Hypoxia Pathway Proteins are Master Regulators of Erythropoiesis.

Watts D, Gaete D, Rodriguez D, Hoogewijs D, Rauner M, Sormendi S Int J Mol Sci. 2020; 21(21).

PMID: 33143240 PMC: 7662373. DOI: 10.3390/ijms21218131.


Coping with hypoxemia: Could erythropoietin (EPO) be an adjuvant treatment of COVID-19?.

Soliz J, Schneider-Gasser E, Arias-Reyes C, Aliaga-Raduan F, Poma-Machicao L, Zubieta-Calleja G Respir Physiol Neurobiol. 2020; 279:103476.

PMID: 32522574 PMC: 7275159. DOI: 10.1016/j.resp.2020.103476.


References
1.
Prabhakar N, Jacono F . Cellular and molecular mechanisms associated with carotid body adaptations to chronic hypoxia. High Alt Med Biol. 2005; 6(2):112-20. DOI: 10.1089/ham.2005.6.112. View

2.
Jelkmann W . Effects of erythropoietin on brain function. Curr Pharm Biotechnol. 2005; 6(1):65-79. DOI: 10.2174/1389201053167257. View

3.
Eckardt K, Kurtz A . Regulation of erythropoietin production. Eur J Clin Invest. 2005; 35 Suppl 3:13-9. DOI: 10.1111/j.1365-2362.2005.01525.x. View

4.
Hundahl C, Stoltenberg M, Fago A, Weber R, Dewilde S, Fordel E . Effects of short-term hypoxia on neuroglobin levels and localization in mouse brain tissues. Neuropathol Appl Neurobiol. 2005; 31(6):610-7. DOI: 10.1111/j.1365-2990.2005.00657.x. View

5.
Stockmann C, Fandrey J . Hypoxia-induced erythropoietin production: a paradigm for oxygen-regulated gene expression. Clin Exp Pharmacol Physiol. 2006; 33(10):968-79. DOI: 10.1111/j.1440-1681.2006.04474.x. View